Advances in the extraction methods for the environmental analysis of non-steroidal anti-inflammatory drugs (NSAIDs)

被引:7
|
作者
Rodriguez-Saldana, Veronica [1 ]
Castro-Garcia, Cesar [1 ]
Rodriguez-Maese, Rogelio [1 ]
Leal-Quezada, Luz O. [1 ]
机构
[1] Adv Mat Res Ctr CIMAV SC, Environm & Energy Dept, Miguel Cervantes 120, Chihuahua 31136, Mexico
关键词
Non-steroidal anti-inflammatory drugs (NSAIDs); Extraction techniques; Water samples; Analytical performance; Validation parameters; SOLID-PHASE EXTRACTION; PERFORMANCE LIQUID-CHROMATOGRAPHY; BAR SORPTIVE EXTRACTION; METAL-ORGANIC FRAMEWORK; MICROWAVE-ASSISTED EXTRACTION; WATER SAMPLES; IONIC LIQUIDS; ACIDIC DRUGS; MICROEXTRACTION; PHARMACEUTICALS;
D O I
10.1016/j.trac.2023.117409
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Monitoring of non-steroidal anti-inflammatory drugs (NSAIDs) in environmental samples is an important step in understanding the widespread of these emerging pollutants in different environmental compartments, mainly water, and encouraging their regulation. The extraction process is critical in order to isolate these analytes from complex water matrices, improving their preconcentration, and accurate quantification. Several extraction methods have been developed and validated in the past decade and many of them have been successfully applied in the analysis of NSAIDs in water samples. This review performs a discussion of the advances of these extraction methods with emphasis on their validation parameters and analytical performance. We retrieved studies in which different extraction methods were developed for the determination of NSAIDs in water samples from two different databases using several keywords after an inclusion-exclusion process. The characteristics of the extraction methods, including the development process, NSAIDs determined, coupled analytical technique, and limits of detection, as well as other performance parameters, were assessed. Additionally, the advantages and limitations of each method such as extraction time, analytical performance, reusability, and range of application, were also discussed.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AND ARTICULAR-CARTILAGE INTEGRITY
    WALTON, EA
    STEVENS, RW
    GHOSH, P
    TAYLOR, TKF
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1981, 11 (01) : 147 - 149
  • [42] Non-steroidal anti-inflammatory drugs (NSAIDs): Physiotherapists' use, knowledge and attitudes
    Grimmer, K
    Kumar, S
    Gilbert, A
    Milanese, S
    AUSTRALIAN JOURNAL OF PHYSIOTHERAPY, 2002, 48 (02): : 82 - 92
  • [43] GASTROINTESTINAL LESIONS DURING TREATMENT WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)
    FESTEN, HPM
    NETHERLANDS JOURNAL OF MEDICINE, 1989, 35 (5-6): : 327 - 333
  • [44] Patient awareness of the adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs)
    Wynne, HA
    Long, A
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (02) : 253 - 256
  • [45] Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs)
    Boehncke, S
    Boehncke, WH
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (40) : 2249 - 2252
  • [46] Gastrointestinal side-effects of non-steroidal anti-inflammatory drugs (NSAIDs)
    Bolten, W.
    GASTROENTEROLOGE, 2006, 1 (03): : 189 - 196
  • [47] The impact of non-steroidal anti-inflammatory drugs (NSAIDs) on breast cancer recurrence
    Duca, M.
    Fievez, L.
    Ameye, L.
    Paesmans, M.
    Sosnowski, M.
    BREAST, 2017, 32 : S91 - S92
  • [48] Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
    Bindu, Samik
    Mazumder, Somnath
    Bandyopadhyay, Uday
    BIOCHEMICAL PHARMACOLOGY, 2020, 180
  • [49] The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19
    Kushner, Pamela
    McCarberg, Bill H.
    Grange, Laurent
    Kolosov, Anton
    Haveric, Anela Lihic
    Zucal, Vincent
    Petruschke, Richard
    Bissonnette, Stephane
    NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2022, 32 (01)
  • [50] The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19
    Pamela Kushner
    Bill H. McCarberg
    Laurent Grange
    Anton Kolosov
    Anela Lihic Haveric
    Vincent Zucal
    Richard Petruschke
    Stephane Bissonnette
    npj Primary Care Respiratory Medicine, 32